107PPhase Ib/II study of biweekly TAS-102 with bevacizumab...

Annals of Oncology 2018 / 11 Vol. 29; Iss. suppl_9

107PPhase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study): Phase Ib results

Kagawa, Y, Satake, H, Kato, T, Oba, K, Yasui, H, Nakamura, M, Watanabe, T, Hirata, K, Muro, K, Komatsu, Y, Yoshino, T, Yamazaki, K, Mishima, H, Kotaka, M, Tsuji, A, Kakeji, Y, Oki, E, Nagata, N, Junic
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy431.021
Date:
November, 2018
File:
PDF, 91 KB
2018
Conversion to is in progress
Conversion to is failed